ASHLEY DAY: Open Payments
NPI 1750637930 · MORRISTOWN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$596 in 35 payments from 11 companies in 2025. Trend: 2023 $1,387 · 2024 $912 · 2025 $596
Food & beverage: $596
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 10 | $141 |
| Astellas Pharma US Inc | 4 | $79 |
| GlaxoSmithKline, LLC. | 4 | $78 |
| PFIZER INC. | 4 | $68 |
| E.R. Squibb & Sons, L.L.C. | 4 | $64 |
| Exelixis Inc. | 2 | $38 |
| Agios Pharmaceuticals, Inc. | 2 | $37 |
| GENZYME CORPORATION | 2 | $37 |
| Lilly USA, LLC | 1 | $20 |
| Cumberland Pharmaceuticals, Inc. | 1 | $19 |
Products named: Fabhalta, OJJAARA, REBLOZYL, Vyloy, CABOMETYX, BOSULIF, PYRUKYND, IBRANCE.
Industry payments across NJ — which companies pay providers there.
